BCL2 and plasmacytoma: Although we have no indication about the eventual supplemental hits supporting the growth of plasmacytoma in aged BCL2 mice from our current study, acquired genetic or epigenetic anomalies are likely since no tumor arises in young mice, whatever the BCL2 expression dosage.